Cargando…

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma

BACKGROUND: Lung adenocarcinomas (LUAD) is the most common histological subtype of lung cancers. Tumor immune microenvironment (TIME) is involved in tumorigeneses, progressions, and metastases. This study is aimed to develop a robust immune‐related signature of LUAD. METHODS: A total of 1774 LUAD ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Sijin, Guo, Wei, Wang, Zhen, Wang, Xin, Zhang, Guochao, Zhang, Hao, Li, Renda, Gao, Yibo, Qiu, Bin, Tan, Fengwei, Gao, Yushun, Xue, Qi, Gao, Shugeng, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433810/ https://www.ncbi.nlm.nih.gov/pubmed/32592319 http://dx.doi.org/10.1002/cam4.3240

Ejemplares similares

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients
por: Gao, Yibo, et al.
Publicado: (2020)

Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
por: Sun, Sijin, et al.
Publicado: (2021)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021)

Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients
por: Zeng, Qingpeng, et al.
Publicado: (2021)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection
por: He, Huayu, et al.
Publicado: (2020)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma
por: Gao, Yushun, et al.
Publicado: (2016)

Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer
por: Liu, Zixu, et al.
Publicado: (2023)

Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma
por: Zhao, Chenguang, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma
por: Zhang, Guochao, et al.
Publicado: (2021)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
por: Li, Tianjiao, et al.
Publicado: (2019)

Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018)

Identification of a 6‐lncRNA prognostic signature based on microarray re‐annotation in gastric cancer
por: Ma, Bin, et al.
Publicado: (2019)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

Uniportal versus multiportal thoracoscopic sleeve lobectomy for the surgical treatment of centrally located lung cancer: a single institution experience
por: Zhao, Jun, et al.
Publicado: (2020)

An immune‐related prognostic signature for predicting breast cancer recurrence
por: Tian, Zelin, et al.
Publicado: (2020)

Identification of a 9‐gene prognostic signature for breast cancer
por: Tian, Zelin, et al.
Publicado: (2020)

Air pollution particles hijack peroxidasin to disrupt immunosurveillance and promote lung cancer
por: Wang, Zhenzhen, et al.
Publicado: (2022)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods
por: Li, Xiao, et al.
Publicado: (2019)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
por: Croft, Wayne, et al.
Publicado: (2023)

Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25‐gene prognostic signatures model
por: Liu, Yushan, et al.
Publicado: (2021)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2021)

Sintilimab for the treatment of non-small cell lung cancer
por: Zhang, Lin, et al.
Publicado: (2022)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tt5fbu7tibin72ac9gao3ojiph